z-logo
Premium
Initial Experience with a Co‐Radial Bipolar Pacing Lead
Author(s) -
TANG CHUEN,
YEUNGLAIWAH JOHN A.,
QI ANZHEN,
MILLS PAULINE,
CLARK JACQUELINE,
TYERS FRANK
Publication year - 1997
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.1997.tb03570.x
Subject(s) - lead (geology) , medicine , implant , ventricular pacing , coaxial , cardiac resynchronization therapy , perioperative , cardiology , surgery , heart failure , ejection fraction , electrical engineering , geomorphology , geology , engineering
A new type of endocardial bipolar pacing lead has been designed to overcome the potential drawbacks of the conventional coaxial bipolar pacing had. We prospectively evaluated the new co‐radial bipolar pacing leads (Intermedics Thin Line), which are thinner (5 Fr vs 6—8 Fr) than standard coaxial bipolar leads. X‐ray visibility and lead handling were subjectively assessed (excellent, good, adequate, or poor) at implant; lead impedance, sensitivity threshold, and pacing threshold were measured at implant, then at 1, 3. 6, 12, and 18 months. The results were as follows: 103 patients (51 M; age 63.8 ± 17.4 years) received 71 atrial (A) and 89 ventricular (V) leads. X‐ray visibility was excellent in 59/103; good in 23/103; adequate in 11/103; and poor in 10/103. Overall handling was excellent in 56/71 A and 69/89 V; good in 11/71 A and 18/89 V; adequate in 3/71 A and 1/89 V; poor in 1/71 A and 1/89 V. There were two perioperative complications. At implant: impedance in A and V were 370.1 ± 74.7 and 501.5 ± 124.4 Ω, sensing thresholds in A and V were 3.0 ± 1.5 and 9.9 ± 5.0 mV, pacing thresholds at 0.45 ms in A and V were 0.59 ± 0.21 and 0.41 ± 0.15 volt, respectively. At 1, 3, 6. 12, and 18 months of follow‐up: no pacing lead related complications were reported; pacing lead characteristics remained outstanding and stable. This new lead appears to have significant clinical advantages over the conventional coaxial bipolar pacing lead. Long‐term follow‐up is required to confirm its reliability and chronic performance characteristics.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here